Hearing Loss Trial, Recruiting (NCT06930560)

Hearing Loss Trial, Recruiting NCT06930560 Sponsor: Johns Hopkins University Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06930560 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 60 and 100 years old
You speak English
You have been diagnosed with Alzheimer's disease or a related form of dementia, based on standard medical guidelines
You have hearing loss in your better ear that is above a mild level (confirmed by a hearing test)
You have a caregiver or someone close to you who is at least 18 years old, can attend all study visits with you, and helps supervise your care
If you take medications for mood, behaviour, or mental health symptoms (such as antidepressants or antipsychotics), your dose has been stable for at least 2 weeks

Who may not be able to join:

You currently use a hearing aid or any other device to help you hear
You have a medical reason why wearing a hearing aid would not be safe for you (for example, an ear that is draining fluid)
You are unable to attend a follow-up visit one month after joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Esther Oh, MD, PhD, Johns Hopkins University

Phone: 410-550-0925

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06930560

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 410-550-0925

More information: https://clinicaltrials.gov/study/NCT06930560

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 60 and 100 years old
You speak English
You have been diagnosed with Alzheimer's disease or a related form of dementia, based on standard medical guidelines
You have hearing loss in your better ear that is above a mild level (confirmed by a hearing test)
You have a caregiver or someone close to you who is at least 18 years old, can attend all study visits with you, and helps supervise your care
If you take medications for mood, behaviour, or mental health symptoms (such as antidepressants or antipsychotics), your dose has been stable for at least 2 weeks

Who may not be able to join:

You currently use a hearing aid or any other device to help you hear
You have a medical reason why wearing a hearing aid would not be safe for you (for example, an ear that is draining fluid)
You are unable to attend a follow-up visit one month after joining the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

15 October 2025

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Distress as assessed by the Neuropsychiatric Inventory (NPI-Q)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov